The Ave-Rec Phase II Trial of PD-L1/PD-1 Blockade with Avelumab Plus Chemoradiotherapy for Resectable ESMO High Risk Rectal Cancers
ANNALS OF ONCOLOGY(2023)
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined